Status:
COMPLETED
ATAC - Quality of Life Sub-Protocol
Lead Sponsor:
AstraZeneca
Conditions:
Quality of Life
Eligibility:
FEMALE
45+ years
Phase:
PHASE3
Brief Summary
To compare Quality of Life between the ARIMIDEX group, the NOLVADEX group and the ARIMIDEX plus NOLVADEX combination group during the first two years of treatment. (a) To compare the difference in Qua...
Eligibility Criteria
Inclusion
- Eligible for entry into the main ATAC trial 1033IL/0029
- Completion of a baseline questionnaire
Exclusion
- Excluded from entry into the main ATAC trial (1033IL/0029)
- If, in the investigators opinion, the patient would be unable to comply with this sub-protocol due to psychiatric or literacy reasons
Key Trial Info
Start Date :
April 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2004
Estimated Enrollment :
308 Patients enrolled
Trial Details
Trial ID
NCT00784680
Start Date
April 1 1998
End Date
April 1 2004
Last Update
May 1 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.